Top compounds associated with response to PRAMEF12


Feature Type Standardized
Nominal ANOVA
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.061 0.05
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.069 0.05
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.05
mRNA MI-1 CTRPv2 pan-cancer AAC 0.075 0.05
mRNA SL 0101-1 GDSC1000 pan-cancer AAC -0.066 0.05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.14 0.06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.07
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.069 0.07
Download CSV